Literature DB >> 17658870

Synthesis and characterization of tetrahedral and square planar Bis(iminopyrrolyl) complexes of cobalt(II).

Sónia A Carabineiro1, Leonel C Silva, Pedro T Gomes, Laura C J Pereira, Luís F Veiros, Sofia I Pascu, M Teresa Duarte, Sónia Namorado, Rui T Henriques.   

Abstract

A series of 2-iminopyrrole ligand precursors with increasing bulkiness [HNC4H3C(R)=N-2,6-R'2C6H3] (R = R' = H, 1a; R = Me, R'= H, 1b; R = H, R' = Me, 1c; R = R' = Me, 1d; R = H, R' = iPr, 1e; R = Me, R' = iPr, 1f) were synthesized and deprotonated with NaH to give the corresponding iminopyrrolyl sodium salts 2a-f. A set of homoleptic bis-ligand Co(II) complexes of the type [Co(kappa2N,N'-NC4H3C(R)=N-2,6-R'2C6H3)2] (R = R'= H, 3a; R = Me, R'= H, 3b; R = H, R' = Me, 3c; R = R' = Me, 3d; R = H, R' = iPr, 3e; R = Me, R' = iPr, 3f) was prepared by reaction of CoCl2 with the corresponding iminopyrrolyl sodium salts 2a-f. The new complexes were characterized by elemental analysis, magnetic susceptibility measurements, in powder and in solution, UV/vis/NIR, and, in some cases, X-ray crystallography. According to X-ray diffraction and magnetic measurements, the Co complexes 3a-e proved to be tetrahedral, which is the preferred geometry for Co(II) compounds. However, a square planar geometry is observed in the case of 3f, as determined by several characterization techniques. In this case, DFT calculations suggest the square planar geometry is slightly more stable than the tetrahedral one probably due to a combination of steric and electronic reasons.

Entities:  

Year:  2007        PMID: 17658870     DOI: 10.1021/ic062125w

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  1 in total

1.  DNA Binding, Cleavage and Antibacterial Activity of Mononuclear Cu(II), Ni(II) and Co(II) Complexes Derived from Novel Benzothiazole Schiff Bases.

Authors:  Narendrula Vamsikrishna; Marri Pradeep Kumar; Somapangu Tejaswi; Aveli Rambabu
Journal:  J Fluoresc       Date:  2016-05-11       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.